skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
  • Close Icon

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Show More

Products

Show More

Show More

42 Total results for product and free and sample content found

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

Pharma Finds Its Way in AI

By Leah Samuel 06 Dec 2019

Analysis

Early adopters of artificial intelligence are discovering how best to use it. Some of them are sharing lessons they have learned. 

In Vivo: 医療用医薬品・医療機器産業の経営層向けニュース

From US To EU: Young Biotechs Going It Alone

28 Nov 2019

Europe’s patchwork of reimbursement agencies make it a daunting place for a small US biotech to do business. Traditionally large pharma partners or CMSOs have provided an experienced hand to hold, but as a new wave of gene therapies and orphan drugs get the EMA green light, smaller drug developers are applying innovation to commercialization and choosing to go solo.

Generics Bulletin: ジェネリック&バイオシミラーニュース

Lupin Offloads Kyowa For $525m But Not Exiting Japan

By Vibha Ravi 13 Nov 2019

Lupin plans to invest in acquisitions and organic growth in the US and India after selling Japanese subsidiary Kyowa Pharma for an enterprise value of around $525m to Japan private equity group Unison Capital. But the Indian firm stresses it is not exiting Japan and will continue to look for marketing partnerships.

Topic deal-trends strategy

Generics Bulletin: ジェネリック&バイオシミラーニュース

Teva Debuts US Rituximab At A 10% Discount

08 Nov 2019

Teva and Celltrion have launched the first biosimilar rituximab in the US, introducing Truxima at a 10% discount to Roche’s Rituxan.

Topic biosimilars strategy

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

Ready, Set, Lowest: Who Won China's Latest Drug Bidding War?

18 Oct 2019

Ready, Set, Lowest: Who Won China's Latest Drug Bidding War?

Multinationals are feeling the heat to win in China's latest drug procurement battle. The winning prices have surprised even previous winners and may have a profound and long-lasting impact on the pharma sector.

Topic deal-trends strategy

Meddevicetracker: 医療機器の市場調査分析・データベース

Introducing Meddevicetracker's Market Analysis Tool

02 Aug 2019

Introducing Meddevicetracker's Market Analysis Tool

Find and manipulate the essential medical devices and diagnostics market intelligence you rely on from Meddevicetracker’s Market Analysis Reports with Meddevicetracker’s new interactive Market Analysis tool. 

Topic Strategy Business strategies Company analysis

In Vivo: 医療用医薬品・医療機器産業の経営層向けニュース

Meet the 2019 Titans of Pharma

31 Jul 2019

Meet the 2019 Titans of Pharma

Get exclusive info on the leaders of the Pharma industry.The 2019 Titan of Pharma infographic is a snapshot of the industry’s top leaders and the businesses they oversee.

Topic company-analysis strategy

Biomedtracker: 開発中医薬品をFDA承認確率で評価

Biomedtracker Q3 2019 Outlook Report Extract

29 Jul 2019

Biomedtracker Q3 2019 Outlook Report Extract

In this report, we cover catalysts from 27 drugs, devices and diagnostics expected to occur in Q3 2019. For each drug, the likelihood of Phase/PDUFA review success and overall Likelihood of Approval (LOA) given their particular phase, drug class, and disease group are provided. These data points were provided using a combination of Pharmapremia, Informa’s drug development benchmarking product utilizing Biomedtracker’s LOA data to assist in informed decisions about drug pipeline prioritization, partnerships, and acquisitions, and drug approval data from Biomedtracker.   

Topic Drug development landscape Drug review Research Strategy

お問い合わせ&レポートストア

専任スタッフによるデモンストレーションを兼ねたサービスの詳しいご説明、または無料トライアルを常時受け付けています。ご希望の場合は下記のフォームよりお気軽にお申し込みください。

*一部のサービスでは無料トライアルをご利用になれません。

ご質問等ございましたらお気軽にご連絡下さい。

日本(平日:9時~18時)
電話:+81 (0)3 6273 4260
Email:inquiry.jp@informa.com

オンラインショップのレポートストアでは、医療用医薬品の市場調査・分析レポートを常時1000本以上販売しています。レポート1本単位で購入でき、オンラインでご提供いたします。

お探しの情報が見つからない場合はお問い合わせ先までお気軽にご連絡ください。